Pushpay (-10.6%), the church management software company plunged to $1.10 after rumors surfaced that its buyout would not be progressing. Pushpay would not confirm or deny the rumor, although noted that they were aware of the market speculation and were abiding by its NZX continuous disclosure obligation. A cooperative bid from BGH Capital and Sixth Street...
Bit of a messy one, but looks like theyve got control again Ready to move out, target in blue Holding
Time to unload strategically pharma stocks for 6-12 months. 66 first target
ENTRY: 1.73 SL: 1.62 TP: 1.92 - ADX>20 - RSI<50,RSI<70 - Daily RS +ve - Daily FFI +ve - Daily MACD +ve - Weekly RS +ve - Weekly FFI +ve - Weekly MACD +ve - Breakout of down trendline and HVN with high volume on 24 Aug 2021. - Retraced with lower volume and tested down trendline a few times. - Breakout of range with high volume today.
As the PPH dropped 15% below the 200sma, OBV barely moved lower compared to the drop. (Between purple vertical lines). This is considered a Bullish Divergence . Now with a strong pullback, we are half way to reach past highs; but this time with an OBV we have not yet seen since Feb, 2018. Ready to buy the dip!
All about Suuport and Resistence Will it break or will it bounce off ? What are Earnings on this ? What are the prospects ? In this Setup i lean towards Hitting Bottom Target Will See
Pepkor Holdings Ltd. is a diversified retail group that has a significant footprint in Africa that is listed on the Johannesburg Stock Exchange. With over 5100 stores in 12 countries, Pepkor is truly a retail giant in Africa. The group has 17 store brands over the retail industry, ranging from affordable quality clothing outlets to high-class furniture outlets....
If you look at my related idea, you can see $PPH wicked perfectly off the 50 fib retracement. This is regarded as a 'healthy' pull back. It also wicked into an OB for some liquidity. However, not overly convinced as of yet. Temporarily bullish due to fisher break and RVGI reset. If PPH moves sideways through trend line, builds more volume as support, we could see...
I expect big pharma to love the opportunity to get the chance to trial drugs on humans using informed consent as djt just signed the 'right to try act'. Should be good for them and the terminally ill tbh GL HF xoxo snoop